News und Analysen
Why Shares of Fresenius Medical Jumped This Week
Shares of Fresenius Medical Care (NYSE: FMS) were up more than 11% for the week as of Friday at 1:30 p.m. ET, according to data provided by S&P Global Market Intelligence. The German healthcare
UnitedHealth Group (UNH) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
UnitedHealth Group (NYSE: UNH)Q2 2023 Earnings CallJul 14, 2023, 8:45 a.m. ET
Operator
Source Fool.com
UnitedHealth Group (UNH) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
UnitedHealth Group (NYSE: UNH)Q2 2023 Earnings CallJul 14, 2023, 8:45 a.m. ET
Operator
Source Fool.com
Why Shares of UnitedHealth Group Are Up Friday
Shares of UnitedHealth Group (NYSE: UNH), the nation's largest private medical insurer, were up more than 6.6% as of 11 a.m. ET on Friday after the company reported second-quarter earnings. The heal
Why Shares of UnitedHealth Group Are Up Friday
Shares of UnitedHealth Group (NYSE: UNH), the nation's largest private medical insurer, were up more than 6.6% as of 11 a.m. ET on Friday after the company reported second-quarter earnings. The heal
3 Reasons to Buy Viatris Stock, and 1 Reason to Sell
Buying shares of a generic drug manufacturer like Viatris (NASDAQ: VTRS) isn't the right move for everyone. While most investors would look for such companies to have a long history of bulletproof
3 Reasons to Buy Viatris Stock, and 1 Reason to Sell
Buying shares of a generic drug manufacturer like Viatris (NASDAQ: VTRS) isn't the right move for everyone. While most investors would look for such companies to have a long history of bulletproof
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
2 Biotech Stocks That Could Make You Richer
When looking for stocks that can make one richer, investors often start with names they know. The problem is that the names they know also tend to be the names that everyone knows, and these stocks
Vertex Pharmaceuticals: Buy at the High?
Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed nearly 20% so far this year. And that leaves the stock trading a few dollars off its record high. It's not surprising Vertex has advanced. The
Vertex Pharmaceuticals: Buy at the High?
Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed nearly 20% so far this year. And that leaves the stock trading a few dollars off its record high. It's not surprising Vertex has advanced. The
Vertex Pharmaceuticals: Buy at the High?
Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed nearly 20% so far this year. And that leaves the stock trading a few dollars off its record high. It's not surprising Vertex has advanced. The
Why Novavax Stock Tumbled 28% in the First Half of 2023
Shares of Novavax (NASDAQ: NVAX) lost 28% of their value in the first six months of the year, according to data from S&P Global Market Intelligence, extending a downtrend that began in early 2022
Why Shares of GoodRx Holdings Climbed This Week
Share of GoodRx Holdings (NASDAQ: GDRX) rose more than 32% for the week, as of Thursday at 2:15 p.m. ET, according to data provided by S&P Global Market Intelligence. The healthcare stock is up more
Is Amgen's Dividend Safe?
Amgen (NASDAQ: AMGN) is a global leader in biotechnology, with a market capitalization of over $121 billion. The company has a proven track record of developing breakthrough therapies for
Is Amgen's Dividend Safe?
Amgen (NASDAQ: AMGN) is a global leader in biotechnology, with a market capitalization of over $121 billion. The company has a proven track record of developing breakthrough therapies for
Is Amgen's Dividend Safe?
Amgen (NASDAQ: AMGN) is a global leader in biotechnology, with a market capitalization of over $121 billion. The company has a proven track record of developing breakthrough therapies for
2 Top Healthcare Stocks to Buy Right Now
When you invest in industries that are positioned to capitalize on secular trends, owning wonderful businesses for the long haul is all it takes to build wealth and passive income. As the world's
2 Top Healthcare Stocks to Buy Right Now
When you invest in industries that are positioned to capitalize on secular trends, owning wonderful businesses for the long haul is all it takes to build wealth and passive income. As the world's
2 No-Brainer Healthcare Stocks to Buy With $100 Right Now
Investing $100 can be a good amount to get started in stocks, especially if you're using a brokerage that charges low commission fees or none at all. And over time, you can steadily grow your
2 No-Brainer Healthcare Stocks to Buy With $100 Right Now
Investing $100 can be a good amount to get started in stocks, especially if you're using a brokerage that charges low commission fees or none at all. And over time, you can steadily grow your
2 No-Brainer Healthcare Stocks to Buy With $100 Right Now
Investing $100 can be a good amount to get started in stocks, especially if you're using a brokerage that charges low commission fees or none at all. And over time, you can steadily grow your
Why Isn't Biogen Stock Soaring After This Major FDA Approval?
Investors in Biogen (NASDAQ: BIIB) got some great news last week as the Food and Drug Administration (FDA) approved the company's Alzheimer's drug Leqembi. But despite the big win, the stock didn't
Why Isn't Biogen Stock Soaring After This Major FDA Approval?
Investors in Biogen (NASDAQ: BIIB) got some great news last week as the Food and Drug Administration (FDA) approved the company's Alzheimer's drug Leqembi. But despite the big win, the stock didn't
Why Isn't Biogen Stock Soaring After This Major FDA Approval?
Investors in Biogen (NASDAQ: BIIB) got some great news last week as the Food and Drug Administration (FDA) approved the company's Alzheimer's drug Leqembi. But despite the big win, the stock didn't